Becton, Dickinson and Company BDX

183.82 4.59 2.56% as of 25 Sep
Market cap
$48.8B
P/E
55.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

Becton, Dickinson and Company (BDX) P/E ratio

As of 25 September 2026, Becton, Dickinson and Company (BDX) trades at a P/E ratio of 55.4×. Over the past ten years it has ranged from 0.0× (June 2018) to 414× (October 2018); the current reading is higher than 82% of that period. That is above the Medical Instruments & Supplies industry median of 34.2× and above the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2025 25.2× (20.90%)
FY2024 31.9× (21.56%)
FY2023 40.6× 37.23%
FY2022 29.6× 8.45%
FY2021 27.3× (57.95%)
FY2020 64.9× 32.45%
FY2019 49.0× (88.16%)
FY2018 414× 1,211.19%
FY2017 31.6× 5.09%
FY2016 30.0× 2.72%

Quarterly

Period P/E ratio Change
Jun 2026 45.6× 14.51%
Mar 2026 39.8× 59.93%
Dec 2025 24.9× (1.22%)
Sep 2025 25.2× 3.64%
42 more quarters

Against its own ten years

Low 0.0× High 414×
Ten-year median 34.6×
Current reading's percentile 82

P/E ratio against peers

Company P/E ratio
BAX Baxter International Inc. compare n/m
SOLV Solventum Corporation compare 10.9×
RMD ResMed Inc. compare 21.3×
ISRG Intuitive Surgical, Inc. compare 45.8×
WST West Pharmaceutical Services, Inc. compare 47.1×
ALC Alcon compare 49.2×
BDX Becton, Dickinson and Company 55.4×
RGEN Repligen Corporation compare 253×
MDLN Medline Inc. compare —
Medical Instruments & Supplies industry median 34.2×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on BDX